Relating to wholesale importation of prescription drugs in this state.

HB 1319 establishes a program allowing Texas to import prescription drugs from licensed Canadian or European Union suppliers at lower costs. It requires the Health and Human Services Commission to contract with approved wholesalers and foreign suppliers, develop a registration system for pharmacies and health plans, publish a list of eligible drugs with prices, and ensure compliance with federal tracking rules. The program directly affects Texas consumers seeking lower-cost medications and healthcare providers participating in the importation system. It prohibits distributing imported drugs outside Texas and aims to provide cost savings while meeting federal safety requirements under 21 U.S.C. § 360eee-1.